Chong Kun Dang Pharmaceutical Corp. (KRX: 185750)
South Korea
· Delayed Price · Currency is KRW 96,300
+300 (0.31%)
Nov 15, 2024, 3:30 PM KST
Chong Kun Dang Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Market Capitalization | 1,225,039 | 1,665,714 | 1,001,821 | 1,312,267 | 2,572,971 | 1,049,862 | Upgrade
|
| Market Cap Growth | 25.13% | 66.27% | -23.66% | -49.00% | 145.08% | -0.19% | Upgrade
|
| Enterprise Value | 1,104,415 | 1,643,508 | 1,090,151 | 1,317,516 | 2,555,291 | 1,080,450 | Upgrade
|
| Last Close Price | 97000.00 | 130900.00 | 77546.69 | 98750.42 | 190322.77 | 77267.88 | Upgrade
|
| PE Ratio | 5.79 | 7.84 | 12.28 | 30.17 | 27.31 | 18.87 | Upgrade
|
| Forward PE | - | 18.84 | 11.98 | 14.96 | 28.32 | 21.26 | Upgrade
|
| PS Ratio | 0.74 | 1.00 | 0.67 | 0.98 | 1.97 | 0.97 | Upgrade
|
| PB Ratio | 1.40 | 2.04 | 1.61 | 2.32 | 4.66 | 2.21 | Upgrade
|
| P/TBV Ratio | 1.55 | 2.18 | 1.68 | 2.41 | 4.83 | 2.29 | Upgrade
|
| P/FCF Ratio | 5.58 | 6.01 | 43.87 | - | 35.89 | 18.93 | Upgrade
|
| P/OCF Ratio | 4.84 | 5.24 | 14.79 | 101.70 | 24.66 | 13.58 | Upgrade
|
| PEG Ratio | 8.48 | 8.48 | 8.48 | 8.48 | 8.48 | 3.17 | Upgrade
|
| EV/Sales Ratio | 0.66 | 0.98 | 0.73 | 0.98 | 1.96 | 1.00 | Upgrade
|
| EV/EBITDA Ratio | 4.02 | 5.79 | 7.60 | 10.78 | 17.30 | 11.07 | Upgrade
|
| EV/EBIT Ratio | 4.65 | 6.66 | 9.92 | 13.90 | 20.62 | 14.49 | Upgrade
|
| EV/FCF Ratio | 5.03 | 5.93 | 47.74 | - | 35.65 | 19.48 | Upgrade
|
| Debt / Equity Ratio | 0.25 | 0.27 | 0.38 | 0.42 | 0.25 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | 0.79 | 0.77 | 1.64 | 1.94 | 0.92 | 1.21 | Upgrade
|
| Debt / FCF Ratio | 0.98 | 0.79 | 10.32 | - | 1.90 | 2.13 | Upgrade
|
| Asset Turnover | 1.26 | 1.32 | 1.37 | 1.35 | 1.49 | 1.43 | Upgrade
|
| Inventory Turnover | 3.28 | 3.79 | 3.82 | 4.13 | 4.87 | 5.27 | Upgrade
|
| Quick Ratio | 1.29 | 1.32 | 1.16 | 1.30 | 1.19 | 1.05 | Upgrade
|
| Current Ratio | 1.99 | 1.85 | 1.91 | 2.08 | 1.87 | 1.70 | Upgrade
|
| Return on Equity (ROE) | 27.69% | 29.73% | 13.47% | 7.58% | 17.61% | 11.70% | Upgrade
|
| Return on Assets (ROA) | 11.15% | 12.20% | 6.33% | 5.94% | 8.86% | 6.16% | Upgrade
|
| Return on Capital (ROIC) | 14.70% | 16.29% | 8.28% | 7.95% | 12.10% | 8.26% | Upgrade
|
| Earnings Yield | 17.28% | 12.76% | 8.08% | 3.26% | 3.56% | 5.13% | Upgrade
|
| FCF Yield | 17.93% | 16.63% | 2.28% | -2.69% | 2.79% | 5.28% | Upgrade
|
| Dividend Yield | 1.09% | 0.80% | - | - | - | - | Upgrade
|
| Payout Ratio | 6.26% | 5.46% | 13.88% | 25.30% | 10.12% | 16.40% | Upgrade
|
| Buyback Yield / Dilution | 0.51% | 0.76% | 1.77% | 0.73% | 0.06% | 0.04% | Upgrade
|
| Total Shareholder Return | 1.60% | 1.56% | 1.77% | 0.73% | 0.06% | 0.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.